Mikhail Kalinichev

2.6k total citations
59 papers, 2.1k citations indexed

About

Mikhail Kalinichev is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Mikhail Kalinichev has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 21 papers in Neurology and 16 papers in Molecular Biology. Recurrent topics in Mikhail Kalinichev's work include Botulinum Toxin and Related Neurological Disorders (20 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neuroendocrine regulation and behavior (15 papers). Mikhail Kalinichev is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (20 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neuroendocrine regulation and behavior (15 papers). Mikhail Kalinichev collaborates with scholars based in France, United States and United Kingdom. Mikhail Kalinichev's co-authors include Stephen G. Holtzman, Keith W Easterling, Paul M. Plotsky, Joan I. Morrell, Jay S. Rosenblatt, Declan N.C. Jones, David A. White, C.A. Marsden, Helge A. Slotten and Jim J. Hagan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Comparative Neurology and Scientific Reports.

In The Last Decade

Mikhail Kalinichev

55 papers receiving 2.1k citations

Peers

Mikhail Kalinichev
Mikhail Kalinichev
Citations per year, relative to Mikhail Kalinichev Mikhail Kalinichev (= 1×) peers Freddy Jeanneteau

Countries citing papers authored by Mikhail Kalinichev

Since Specialization
Citations

This map shows the geographic impact of Mikhail Kalinichev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Kalinichev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Kalinichev more than expected).

Fields of papers citing papers by Mikhail Kalinichev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail Kalinichev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Kalinichev. The network helps show where Mikhail Kalinichev may publish in the future.

Co-authorship network of co-authors of Mikhail Kalinichev

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail Kalinichev. A scholar is included among the top collaborators of Mikhail Kalinichev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail Kalinichev. Mikhail Kalinichev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vignaud, Alban, Wendy Noort, Guus C. Baan, et al.. (2024). Muscle type‐specific effects of bilateral abobotulinumtoxinA injection on muscle growth and contractile function in spastic mice. The FASEB Journal. 38(22). e70141–e70141.
2.
Epping-Jordan, Mark P., Françoise Girard, Anne‐Sophie Bessis, et al.. (2023). Effect of the Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulator Dipraglurant on Motor and Non-Motor Symptoms of Parkinson’s Disease. Cells. 12(7). 1004–1004. 7 indexed citations
3.
Muñoz-Lora, Victor Ricardo Manuel, et al.. (2023). The safety of botulinum neurotoxin type A's intraarticular application in experimental animals. SHILAP Revista de lepidopterología. 18. 100155–100155.
4.
Vignaud, Alban, Wendy Noort, Bastijn Koopmans, et al.. (2022). Glycine receptor subunit-β-deficiency in a mouse model of spasticity results in attenuated physical performance, growth, and muscle strength. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 322(5). R368–R388. 3 indexed citations
5.
Doller, Darı́o, Anton Bespalov, Robert F. Miller, M. Pietraszek, & Mikhail Kalinichev. (2020). A case study of foliglurax, the first clinical mGluR4 PAM for symptomatic treatment of Parkinson’s disease: translational gaps or a failing industry innovation model?. Expert Opinion on Investigational Drugs. 29(12). 1323–1338. 14 indexed citations
7.
Elliott, Mark, Sai Liu, Geoffrey Masuyer, et al.. (2019). Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models. Science Advances. 5(1). eaau7196–eaau7196. 33 indexed citations
8.
Donald, Sarah, Mark Elliott, Agnieszka Lewandowska, et al.. (2018). A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo. Pharmacology Research & Perspectives. 6(6). e00446–e00446. 24 indexed citations
9.
Kalinichev, Mikhail, Tansy Donovan-Rodríguez, Françoise Girard, et al.. (2016). ADX71943 and ADX71441, novel positive allosteric modulators of the GABA B receptor with distinct central/peripheral profiles, show efficacy in the monosodium iodoacetate model of chronic osteoarthritis pain in the rat. European Journal of Pharmacology. 795. 43–49. 10 indexed citations
10.
Moloney, Rachel D., Anna V. Golubeva, Richard M. O’Connor, et al.. (2015). Negative allosteric modulation of the mGlu7 receptor reduces visceral hypersensitivity in a stress-sensitive rat strain. Neurobiology of Stress. 2. 28–33. 15 indexed citations
11.
Hwa, Lara S., et al.. (2013). Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice. Psychopharmacology. 231(2). 333–343. 34 indexed citations
12.
Kalinichev, Mikhail, Mélanie Rouillier, Françoise Girard, et al.. (2012). ADX71743, a Potent and Selective Negative Allosteric Modulator of Metabotropic Glutamate Receptor 7: In Vitro and In Vivo Characterization. Journal of Pharmacology and Experimental Therapeutics. 344(3). 624–636. 86 indexed citations
13.
Kalinichev, Mikhail & Lee A. Dawson. (2011). Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania. The International Journal of Neuropsychopharmacology. 14(8). 1051–1067. 55 indexed citations
15.
Kalinichev, Mikhail, et al.. (2008). Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine. Psychopharmacology. 203(4). 693–702. 57 indexed citations
16.
Kalinichev, Mikhail, et al.. (2008). Comparative effects of olanzapine and ziprasidone on hypophagia induced by enhanced histamine neurotransmission in the rat. Behavioural Pharmacology. 19(2). 121–128. 16 indexed citations
17.
Kalinichev, Mikhail, Melanie J. Robbins, Elizabeth M. Hartfield, et al.. (2007). Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague–Dawley rats: A locomotor activity and gene induction study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(2). 414–422. 65 indexed citations
19.
Kalinichev, Mikhail, Keith W Easterling, Paul M. Plotsky, & Stephen G. Holtzman. (2002). Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long–Evans rats. Pharmacology Biochemistry and Behavior. 73(1). 131–140. 410 indexed citations
20.
Kalinichev, Mikhail, Jay S. Rosenblatt, & Joan I. Morrell. (2000). The medial preoptic area, necessary for adult maternal behavior in rats, is only partially established as a component of the neural circuit that supports maternal behavior in juvenile rats.. Behavioral Neuroscience. 114(1). 196–210. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026